Charles D. Thompson

1.3k total citations
39 papers, 877 citations indexed

About

Charles D. Thompson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Charles D. Thompson has authored 39 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 11 papers in Oncology. Recurrent topics in Charles D. Thompson's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers) and Peptidase Inhibition and Analysis (7 papers). Charles D. Thompson is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers) and Peptidase Inhibition and Analysis (7 papers). Charles D. Thompson collaborates with scholars based in United States, India and United Kingdom. Charles D. Thompson's co-authors include Timothy L. Macdonald, William Westlin, Gerhard Hannig, Marion Wittmann, George D. Hartman, Matthew A. Seager, Mark T. Bilodeau, Scott D. Kuduk, Sylvie G. Bernier and William J. Ray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of The Electrochemical Society and Clinical Cancer Research.

In The Last Decade

Charles D. Thompson

39 papers receiving 848 citations

Peers

Charles D. Thompson

CMN

ONCOL

PHARM

Iain Martin United Kingdom

Arnold van Loevezijn Netherlands

Naina Patel United Kingdom

Charles W. Locuson United States

Hamish Ryder Spain

David Thomson United States

Chayan Acharya United States

Evgeny Kiselev United States

Claire Colas United States

Ralf Lotz Germany

Iain Martin United Kingdom

Charles D. Thompson

235 ×0.5

86 ×0.3

CMN

147 ×0.7

ONCOL

167 ×1.0

138 ×1.3

PHARM

Citations per year, relative to Charles D. Thompson Charles D. Thompson (= 1×) peers Iain Martin

Countries citing papers authored by Charles D. Thompson

Since Specialization

Citations

This map shows the geographic impact of Charles D. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Thompson more than expected).

Fields of papers citing papers by Charles D. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Thompson. The network helps show where Charles D. Thompson may publish in the future.

Co-authorship network of co-authors of Charles D. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Thompson. A scholar is included among the top collaborators of Charles D. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Thompson. Charles D. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valenzuela, Belén, et al.. (2023). Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis. Clinical Pharmacokinetics. 62(11). 1533–1550. 6 indexed citations

Thompson, Charles D., et al.. (2018). Bladder calculi causing irreducible urogenital prolapse. BMJ Case Reports. 2018. bcr–2018. 6 indexed citations

Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2014). Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 24(5). 1417–1420. 7 indexed citations

Xu, Yan, Mei Ou, Rena Zhang, et al.. (2014). Quantitation of Physiological and Biochemical Barriers to siRNA Liver Delivery via Lipid Nanoparticle Platform. Molecular Pharmaceutics. 11(5). 1424–1434. 30 indexed citations

Arico-Muendel, Christopher C., Bruce Belanger, Dennis R. Benjamin, et al.. (2013). Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity. Drug Metabolism and Disposition. 41(4). 814–826. 9 indexed citations

Bungard, Christopher J., George D. Hartman, James J. Perkins, et al.. (2011). Discovery of selective glucocorticoid receptor modulator MK-5932. Bioorganic & Medicinal Chemistry. 19(24). 7374–7386. 16 indexed citations

Kuduk, Scott D., Ronald K. Chang, Christina N. Di Marco, et al.. (2011). Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series. Bioorganic & Medicinal Chemistry Letters. 21(6). 1710–1715. 20 indexed citations

Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2010). N-Heterocyclic derived M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(4). 1334–1337. 25 indexed citations

Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2010). Fused heterocyclic M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 21(9). 2769–2772. 14 indexed citations

10.

Kuduk, Scott D., Robert M. DiPardo, Douglas C. Beshore, et al.. (2010). Hydroxy cycloalkyl fused pyridone carboxylic acid M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(8). 2538–2541. 15 indexed citations

11.

Kuduk, Scott D., Christina N. Di Marco, Ronald K. Chang, et al.. (2010). Heterocyclic fused pyridone carboxylic acid M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(8). 2533–2537. 21 indexed citations

12.

Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2009). Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding. Bioorganic & Medicinal Chemistry Letters. 20(2). 657–661. 20 indexed citations

13.

Lazarus, Douglas, Matthew Labenski, James Wakefield, et al.. (2008). An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis. Inflammation Research. 57(1). 18–27. 11 indexed citations

14.

Bernier, Sylvie G., et al.. (2005). Methionine aminopeptidases type I and type II are essential to control cell proliferation. Journal of Cellular Biochemistry. 95(6). 1191–1203. 59 indexed citations

15.

Bernier, Sylvie G., Douglas Lazarus, Matthew Labenski, et al.. (2004). A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis. Proceedings of the National Academy of Sciences. 101(29). 10768–10773. 84 indexed citations

16.

Dieckhaus, Christine M., Charles D. Thompson, Shane Roller, & Timothy L. Macdonald. (2002). Mechanisms of idiosyncratic drug reactions: the case of felbamate. Chemico-Biological Interactions. 142(1-2). 99–117. 57 indexed citations

17.

Thompson, Charles D., et al.. (2000). The Synthesis, In Vitro Reactivity, and Evidence for Formation in Humans of 5-Phenyl-1,3-oxazinane-2,4-dione, a Metabolite of Felbamate. Drug Metabolism and Disposition. 28(4). 434–439. 14 indexed citations

18.

Miller, Thomas A., et al.. (1999). The synthesis and evaluation of temperature sensitive tubulin toxins. Bioorganic & Medicinal Chemistry Letters. 9(3). 407–412. 1 indexed citations

19.

Miller, Thomas A., et al.. (1998). The synthesis and evaluation of benzannelated-azatoxins: The benzazatoxins. Bioorganic & Medicinal Chemistry Letters. 8(9). 1065–1070. 10 indexed citations

20.

Thompson, Charles D., et al.. (1997). Mechanisms of Adrenergic Agonist Induced Allergy Bioactivation and Antigen Formation. Experimental Eye Research. 64(5). 767–773. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact